View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Denizbank A.S.: Key facts and statistics - 2025

A summary company profile, detailing Denizbank A.S.’s business operations and financial highlights.

 PRESS RELEASE

Man Group PLC : Form 8.3 - JTC Plc

Man Group PLC : Form 8.3 - JTC Plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form r...

Maritime Launch Services Inc: 1 director

A director at Maritime Launch Services Inc sold 3,000,000 shares at 0.600CAD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Blair Levin
  • Blair Levin

AMZN/GSAT…Getting a new band of tech giants together

AMZN announced that it is acquiring Apple satellite partner GSAT and that it has also reached an agreement for Amazon Leo to power satellite services for the iPhone and Apple Watch. In this note, we discuss issues related to the government's review of the potential transaction.

 PRESS RELEASE

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2...

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial 78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year survival rate of >80%; Parallel trial without PDS01ADC resulted in 2-year survival rate of ~35% Trials performed in unresectable microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal liver metastases, which constitute the majority of mCRC, and in which immune checkpoint inhibitors have been unsuccessful PRINCET...

 PRESS RELEASE

One and one Green Technologies Expects 22–24% Revenue Increase and 80–...

One and one Green Technologies Expects 22–24% Revenue Increase and 80–85% Net Income Growth for 2025 San Rafael, Bulacan, Philippines, April 15, 2026 (GLOBE NEWSWIRE) -- One and one Green Technologies. INC (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license in the Philippines to import and process hazardous waste as raw materials, today announced selected preliminary unaudited financial results for the full fiscal year ended December 31, 2025. The Company expects revenue for fiscal year 2025 to be in the range of $64.5 mil...

 PRESS RELEASE

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Resul...

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call Call scheduled for today, Wednesday, April 15, 2026, at 5:00 pm ET LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), announced it plans to release its full year 2025 financial results after market close today, Wednesday, Apri...

David Barden
  • David Barden

Brightspeed – Updating our model for 4Q25 and baking in new ABS assump...

Following Brightspeed’s 4Q call on 4/8 and our note discussing the likelihood of the company accessing the ABS market, we are updating our model and valuations under two scenarios including 1) a ‘Complete build’, and a 2) ‘Capital constrained build’. Overall, our model update generates a modest valuation improvement under both scenarios. In the ‘Complete build’ scenario, our updated EV estimate of $10.5bn implies debtholders are completely covered through the "Fourth Out" TL (term loan). In the ...

 PRESS RELEASE

Issue of Equity

Issue of Equity 15 April 2026 HARGREAVE HALE AIM VCT PLC (the “Company”) Allotment of Shares The Board announced on 23 January 2026 that the Company had published an offer document (the “Offer Document") in relation to an offer for subscription of ordinary shares of 1 pence each (the "Ordinary Shares"), to raise up to £20,000,000 with an over-allotment facility to raise up to a further £10,000,000 (the "Offer"). On 15 April 2026, the Company allotted 789,933 new Ordinary Shares pursuant to the Offer, conditional only on trading on the London Stock Exchange plc’s main market for listed se...

Tanco Holdings Berhad: 1 director

A director at Tanco Holdings Berhad bought 794,500 shares at 1.656MYR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

Runway Growth Finance Corp. Announces Date for First Quarter 2026 Fina...

Runway Growth Finance Corp. Announces Date for First Quarter 2026 Financial Results and Conference Call MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY), (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ...

 PRESS RELEASE

Eos Energy Enterprises & TURBINE-X Launch Private Power Infrastructure...

Eos Energy Enterprises & TURBINE-X Launch Private Power Infrastructure Solution for AI, Delivering Hyperscale Capacity in Months, Not Years Joint Development Agreement establishes integrated gas-fired generation and Indensity™ storage architecture to meet accelerating power demands of AI infrastructure PITTSBURGH and HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), and TURBINE‑X Energy, Inc. (“TURBINE‑X”), a dev...

 PRESS RELEASE

Beeline Announces Strategic Partnership with Structured Real Estate Gr...

Beeline Announces Strategic Partnership with Structured Real Estate Group (SRG) to Integrate Its Embedded Mortgage and Title Solutions into SRG’s AI-Driven Real Estate Platform Beeline will offer up to 2,000 mortgages on new homes in Dallas over the next 36 months PROVIDENCE, R.I., April 15, 2026 (GLOBE NEWSWIRE) -- via IBN – Beeline Holdings, Inc. (Nasdaq: BLNE) (“Beeline”) today announced a strategic partnership with Structured Real Estate Group (SRG) to integrate its Embedded Mortgage and Title solutions into SRG’s proprietary AI-driven real estate platform. The collaboration represe...

 PRESS RELEASE

Allogene Therapeutics Announces Nature Communications Publication High...

Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases Study Highlights Dagger® Technology Showing that an Optimized CD70 CAR has the Potential to Protect Against Immune Rejection, Enabling Robust Expansion and Persistence of Allogeneic CAR T Cells in Pre-Clinical ModelsDual CD19/CD70 CAR T Cells Rapidly Eliminated B and T Cells in Systemic Lupus Erythematosus (SLE) Models, Halting Autoantibody ProductionPhase 1 RESOLUTION Dose Escalation Rheumatology Ba...

 PRESS RELEASE

Gorilla Technology Increases Strategic Investment in Astrikos.AI

- Builds on Q4 investment to further advance Gorilla's integrated AI infrastructure strategy across India, USA, and UAE- Appoints Managing Partner of Gorilla Tech Capital to the board of AstrikosLondon, United Kingdom--(Newsfile Corp. - April 15, 2026) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that it has increased its strategic investment in Astrikos.AI ("Astrikos"), the Bengaluru, India-based, real...

 PRESS RELEASE

Aware Sets First Quarter 2026 Webcast for Wednesday, April 29, 2026, a...

Aware Sets First Quarter 2026 Webcast for Wednesday, April 29, 2026, at 5:00 p.m. Eastern Time BURLINGTON, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: AWRE), global leader in biometric identity and authentication solutions, will hold a webcast on Wednesday, April 29, 2026, at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2026. Financial results will be issued in a press release before the call. Aware management will host the webcast presentation, followed by a question-and-answer session. Date: Wednesday, April 29, 2026Time: 5:00 p...

 PRESS RELEASE

Xenon to Present at Upcoming Investor Conferences

Xenon to Present at Upcoming Investor Conferences VANCOUVER, British Columbia and BOSTON, MA, April 15, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at four upcoming investor conferences in the second quarter of 2026. Bloom Burton & Co. Healthcare Investor Conference, Toronto, OntarioCompany Presentation: Wednesday, April 22, 2026, 11:30 am–12:00 pm ...

 PRESS RELEASE

Giftify’s CardCash Reports Highest Average Buyer Order Value Since 202...

Giftify’s CardCash Reports Highest Average Buyer Order Value Since 2020, Reaching $429 in Peak Week of Q1 2026 Average buyer order value up 15.4% year-over-year to $384 through March 22 as buyer spend per transaction reaches multi-year highs across the platform SCHAUMBURG, IL, April 15, 2026 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of CardCash.com, Restaurant.com, and Takeout7.com, and a leader in the incentives and rewards industry, today announced preliminary buyer order value results for CardCash.com through the first eleven weeks of Q1 ...

 PRESS RELEASE

Dime Announces Significant Hires to Advance Growth Plan

Dime Announces Significant Hires to Advance Growth Plan HAUPPAUGE, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- Building upon its reputation as the "bank-of-choice" for talented commercial bankers and the primary beneficiary of disruption in the Metro New York Market, Dime announced the following hires: Meyer Eichler, previously Executive Vice President and Head of Community Markets at Flagstar, has joined as Executive Vice President, Managing Executive Director, and he will lead a team of bankers. Prior to Flagstar, Mr. Eichler was with predecessor bank Signature (for approximately 13 years...

 PRESS RELEASE

Q.E.P. Co., Inc. Raises Regular Quarterly Dividend 10%

Q.E.P. Co., Inc. Raises Regular Quarterly Dividend 10% $0.22 Per Share Payable May 28, 2026 to Stockholders of Record May 1, 2026 BOCA RATON, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- Q.E.P. CO., INC. (OTCQX: QEPC) (“QEP” or the “Company”) today announced that its Board of Directors has approved a 10% increase in its regular quarterly cash dividend to $0.22 per share on its common stock. The dividend is payable on May 28, 2026 to stockholders of record on May 1, 2026. This increase reflects QEP’s continued focus on disciplined capital allocation and long-term shareholder value creation...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch